arrow
M

Mohamed H. Shamji

imperial college london
H指数:61
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Natural Diversity of Grass Pollen in Europe—An EAACI Perspective

欧洲草花粉的自然多样性—<scp>EAACI</scp>观点

2026-10-080
PREAI
The EAACI Declaration of Salamanca: A European Roadmap for Strengthening Undergraduate Medical Education in Allergy and Clinical Immunology

EAACI萨拉曼卡宣言:加强变态反应学和临床免疫学本科医学教育的欧洲路线图

2026-09-240
OAAI
EAACI Spring Meeting 2026: Prevention as Treatment—A New Paradigm
2026-09-010
OAAI
Bridging Rare to Common Diseases: Precision Medicine and the Transforming Landscape of Pediatric Allergy and Immunology

连接罕见病与常见病:精准医学与儿科过敏和免疫学领域的变革图景

2026-08-170
OAAI
Decalogue of the Declaration of Salamanca: Advancing Undergraduate Education in Allergy and Clinical Immunology Across Europe

萨拉曼卡宣言的十项原则:促进欧洲过敏与临床免疫学本科教育

2026-07-120
OAAI
Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures

利用人工智能在过敏,哮喘和环境暴露的免疫学

2026-06-030
OA
Treatment Dose Increase Versus Co-Medication in Allergic Rhinitis: Systematic Review With Dose–Response Network Meta-Analysis

过敏性鼻炎的治疗剂量增加与联合用药比较:剂量-反应网络Meta分析的系统性综述

2026-05-010
OAAI
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal Polyps

首个用于过敏领域的生物类似药:CT-P39(Omlyclo-Omalizumab-Igec)适用于哮喘、慢性自发性荨麻疹和伴有鼻息肉的慢性鼻窦炎

2026-04-250
PRE
Obituary: Sergio Del Giacco (1936–2026)
2026-04-230
PRE
Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force

系统性糖皮质激素在炎症性上呼吸道疾病和哮喘中的危害:EAACI工作组荟萃分析

2026-04-010
PRE
Corrigendum to ‘Skin as the target for allergy prevention and treatment’ [Annals of Allergy, Asthma & Immunology, Volume 133, Issue 2 (2024) 133–143]

勘误:‘Skin as the target for allergy prevention and treatment’ [Allergy, Asthma & Immunology学报,第133卷,第2期(2024年)133–143页]

2026-03-300
OAAI
Risk and Protective Factors for Infection, Severe Disease, and Mortality in Epidemic Respiratory Viruses

感染、重症疾病及死亡在流行性呼吸道病毒中的危险因素和保护因素

2026-03-260
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?

通讯:首个花生(Arachis hypogaea)过敏原口服免疫疗法产品退出销售——这对食物过敏免疫疗法是一个重大挫折?

2026-02-120
PRE